Clinical Trial Update: PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating irreversible electroporation (IRE) for locally advanced pancreatic carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-metastasized Unresectable Pancreatic Carcinoma
• Pancreatic Cancer
• Pancreatic Carcinoma

Drugs mentioned

• Irreversible Electroporation (IRE) (irreversible electroporation)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Locally Advanced Pancreatic Carcinoma (LAPC), Non-metastasized Unresectable Pancreatic Carcinoma | Phase 1, Phase 2 | Status: COMPLETED